La Jolla, CA, United States of America

Edward Golub


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward Golub: Innovator in Immunoglobulin-Binding Polypeptides

Introduction

Edward Golub is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of immunology through his innovative work on immunoglobulin-binding polypeptides. With a total of 2 patents, Golub's inventions have the potential to impact diagnostic and therapeutic applications in medicine.

Latest Patents

Golub's latest patents focus on methods of separating V.sub.H containing immunoglobulins. One patent describes a method that involves admixing an immunoglobulin binding peptide capable of binding to heavy chain variable regions of antibodies in an antigen-independent manner. This method can effectively separate antigen/antibody complexes. Another patent details polypeptides that can bind to immunoglobulin heavy chain variable regions (V.sub.H) in a similar antigen-independent manner. These polypeptides are designed for diagnostic purposes and can enhance the affinity of antibodies for their antigens. Additionally, they can be utilized to isolate V.sub.H containing molecules from solutions.

Career Highlights

Edward Golub is affiliated with the University of California, where he continues to advance research in immunology. His work has garnered attention for its innovative approach to antibody interactions and diagnostics.

Collaborations

Golub has collaborated with notable colleagues such as Maurizio Zanetti and Petar Lenert. Their combined expertise contributes to the advancement of research in immunoglobulin-binding technologies.

Conclusion

Edward Golub's contributions to the field of immunology through his patents on immunoglobulin-binding polypeptides highlight his role as an influential inventor. His work not only enhances our understanding of antibody interactions but also paves the way for future advancements in medical diagnostics and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…